These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 18431250)

  • 1. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.
    Basurto-Islas G; Luna-Muñoz J; Guillozet-Bongaarts AL; Binder LI; Mena R; García-Sierra F
    J Neuropathol Exp Neurol; 2008 May; 67(5):470-83. PubMed ID: 18431250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin is associated with early truncation of tau protein at aspartic acid(421) during the maturation of neurofibrillary tangles in Alzheimer's disease.
    García-Sierra F; Jarero-Basulto JJ; Kristofikova Z; Majer E; Binder LI; Ripova D
    Brain Pathol; 2012 Mar; 22(2):240-50. PubMed ID: 21919991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
    Guillozet-Bongaarts AL; Cahill ME; Cryns VL; Reynolds MR; Berry RW; Binder LI
    J Neurochem; 2006 May; 97(4):1005-14. PubMed ID: 16606369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.
    Jarero-Basulto JJ; Luna-Muñoz J; Mena R; Kristofikova Z; Ripova D; Perry G; Binder LI; Garcia-Sierra F
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1145-61. PubMed ID: 24226268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.
    Gamblin TC; Chen F; Zambrano A; Abraha A; Lagalwar S; Guillozet AL; Lu M; Fu Y; Garcia-Sierra F; LaPointe N; Miller R; Berry RW; Binder LI; Cryns VL
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10032-7. PubMed ID: 12888622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
    Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
    Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
    Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
    J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncation of tau at E391 promotes early pathologic changes in transgenic mice.
    McMillan PJ; Kraemer BC; Robinson L; Leverenz JB; Raskind M; Schellenberg G
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):1006-19. PubMed ID: 22002427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
    García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
    Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.
    Huang Y; Liu XQ; Wyss-Coray T; Brecht WJ; Sanan DA; Mahley RW
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8838-43. PubMed ID: 11447277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
    Nicholls SB; DeVos SL; Commins C; Nobuhara C; Bennett RE; Corjuc DL; Maury E; Eftekharzadeh B; Akingbade O; Fan Z; Roe AD; Takeda S; Wegmann S; Hyman BT
    PLoS One; 2017; 12(5):e0177914. PubMed ID: 28531180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
    Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
    Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.
    Mondragón-Rodríguez S; Basurto-Islas G; Santa-Maria I; Mena R; Binder LI; Avila J; Smith MA; Perry G; García-Sierra F
    Int J Exp Pathol; 2008 Apr; 89(2):81-90. PubMed ID: 18336525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
    Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
    Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.